| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/28/2009 | EP2018184A2 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases |
| 01/28/2009 | EP1861497A4 Protein and its use in diagnosing alzheimer's disease |
| 01/28/2009 | EP1372716B1 Blood cell production via activation of cd163 |
| 01/28/2009 | EP1121135B1 Compositions of beta-glucans and specific immunoglobulins |
| 01/28/2009 | CN101356287A Methods and compositions for the assessment of cardiovascular function and disorders |
| 01/28/2009 | CN101356271A Identification and discrimination of function interdiction anti-ED-B-fibronectin antibody |
| 01/28/2009 | CN101356195A Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 |
| 01/28/2009 | CN101356194A Antibody molecules having specificity for human IL-6 |
| 01/28/2009 | CN101355966A Bispecific single chain Fv antibody molecules and methods of use thereof |
| 01/28/2009 | CN101355965A Methods and compositions for the treatment of persistent infections and cancers by inhibiting the programmed cell death 1 (PD-1) phthway |
| 01/28/2009 | CN101353381A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 01/28/2009 | CN101353371A H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 01/28/2009 | CN101352571A Medicament for treating encephalitis b and preparation method thereof |
| 01/28/2009 | CN100455662C Avianinflu virus H5 subtype emulsion agglutination kit and its use |
| 01/28/2009 | CN100455599C Gene recombinant antibody and its fragment |
| 01/28/2009 | CN100455598C Antibody of anti human CD20 from human resources functionally, and application |
| 01/28/2009 | CN100455596C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482436 Human antihuman interleukin-6 antibody and fragment of antibody |
| 01/27/2009 | US7482435 Immunoglobulin for use in human therapeutics and diagnostics |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482431 KCNQ2 potassium channels |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482128 Anti-feline albumin antibodies |
| 01/27/2009 | US7482117 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 01/27/2009 | US7482016 Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | US7482006 Culturing yeasts, host cells; biosynthesis |
| 01/27/2009 | US7482005 Methods of treating diseases with anti-VEGF antibodies |
| 01/27/2009 | US7482004 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7482000 Point mutations; immunology |
| 01/27/2009 | US7481999 Compounds and methods for modulating OB-cadherin-mediated function |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2361545C Purification of biological substances |
| 01/27/2009 | CA2353483C Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2236837C Detection of mammary tumor virus-like sequences in human breast cancer |
| 01/27/2009 | CA2196339C Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/22/2009 | WO2009012401A1 Antagonist antibodies of protease activated receptor-1 (par1) |
| 01/22/2009 | WO2009012394A1 Monoclonal antibodies against glypican-3 |
| 01/22/2009 | WO2009012382A2 Compositions, kits, and methods for the modulation of immune responses using galectin-1 |
| 01/22/2009 | WO2009012268A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | WO2009012256A1 Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | WO2009012175A1 Antibodies specific for the c-terminal regulatory domain of egfr and their use |
| 01/22/2009 | WO2009011941A2 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 01/22/2009 | WO2009011572A1 Single-domain antigen-binding proteins that bind mammalian igg |
| 01/22/2009 | WO2009011413A1 Production and use of epitope-tagged hepatitis c virus particle |
| 01/22/2009 | WO2009010976A2 Compositions and methods for purifying and crystallizing molecules of interest |
| 01/22/2009 | WO2009010539A2 Receptor for interleukin-6 (il-6) from macaca fascicularis |
| 01/22/2009 | WO2009010474A1 Antibody or fragment thereof recognizing avitagtm and uses thereof |
| 01/22/2009 | WO2009010296A2 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 01/22/2009 | WO2009010290A2 Engineered anti-alpha v- integrin hybrid antibodies |
| 01/22/2009 | WO2009010269A1 Variable tangential flow filtration |
| 01/22/2009 | WO2009010228A1 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 01/22/2009 | WO2009009892A1 Engineered scfv against bovine herpes virus type i |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009882A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009881A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2008121876A3 Non-fucosylated antibodies |
| 01/22/2009 | WO2008121160A3 Optimized antibodies that target cd5 |
| 01/22/2009 | WO2008118970A3 Constructs and libraries comprising antibody surrogate light chain sequences |
| 01/22/2009 | WO2008113916A9 Pharmaceutical composition containing antibodies directed against the herv-w envelope |
| 01/22/2009 | WO2008103849A4 Methods and compounds for lymphoma cell detection and isolation |
| 01/22/2009 | WO2008082519A3 Screening for cd93 (c1qrp)-associated polymorphism(s) in the diagnosis, prevention and treatment of autoimmune diseases |
| 01/22/2009 | WO2008073070A3 Antibodies to a spore specific glycosyl hydrolase |
| 01/22/2009 | WO2008052737A3 Immunochemically equivalent hiv drug analogs |
| 01/22/2009 | US20090025095 Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight |
| 01/22/2009 | US20090023900 Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same |
| 01/22/2009 | US20090023894 Neutralizing Antibody Against HGF |
| 01/22/2009 | US20090023663 Thymosin beta 4 compositions and methods |
| 01/22/2009 | US20090023662 recognize extracellular structures of G protein-coupled receptors; for treating humoral kidney rejection |
| 01/22/2009 | US20090023660 Novel Hemopoietin Receptor Protein, NR12 |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023657 Catecholamine regulated protein |
| 01/22/2009 | US20090023654 Axmi-008, a delta-endotoxin gene and methods for its use |
| 01/22/2009 | US20090023645 AIB1, a novel steroid receptor co-activator |
| 01/22/2009 | US20090023602 Binding polypeptides with restricted diversity sequences |
| 01/22/2009 | US20090023226 Variant Integrin Polypeptides and Uses Thereof |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023207 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/22/2009 | US20090023164 Compositions and methods for the detection of hiv-1/hiv-2 infection |
| 01/22/2009 | US20090023160 Antibodies specific for CYP1B1 |
| 01/22/2009 | US20090023159 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 01/22/2009 | US20090023152 Transcription factor MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 01/22/2009 | US20090023143 Predicting agent for metastasis |
| 01/22/2009 | US20090023139 Method For Site-Specifically Introducing Non-Natural Amino Acid Into Protien Using Mitochondrial Protein and Method For Effectively Preparing Trna |
| 01/22/2009 | US20090022753 Surface proteins of streptococcus pyogenes |
| 01/22/2009 | US20090022748 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 01/22/2009 | US20090022745 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 01/22/2009 | US20090022744 Modified Fc molecules |
| 01/22/2009 | US20090022742 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 01/22/2009 | US20090022738 Multispecific deimmunized CD3-binders |
| 01/22/2009 | US20090022736 Monoclonal Antibodies That Specifically Bind To And Neutralize Bacillus Anthracis Toxin, Compositions, And Methods Of Use |
| 01/22/2009 | US20090022731 Arthritis-associated B cell gene expression |
| 01/22/2009 | US20090022725 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |